News

US FDA advisers to discuss COVID-19 vaccine recommendations on May 22
The U.S. Food and Drug Administration said on Wednesday it will hold a meeting of experts on May 22 to discuss COVID-19 ...
US FDA advisers to discuss COVID-19 vaccine recommendations
The U.S. Food and Drug Administration said on Wednesday it will hold a meeting of experts to discuss COVID-19 vaccine ...
FDA Chief Downplays COVID Boosters After Suggesting No Updated Shots This Season
The head of the U.S. Food and Drug Administration on Tuesday reportedly raised doubts about the need for COVID booster shots ...
FDA names outspoken Covid vaccine critic as the new vaccine chief
Dr. Vinay Prasad was an outspoken critic of the FDA’s response to the pandemic, including the former vaccine chief, Dr. Peter ...
Dr. Vinay Prasad to Head FDA Vaccine, Biologics Division
WEDNESDAY, May 7, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has chosen Dr. Vinay Prasad, a ...
Critic of drug industry and COVID-19 measures to lead FDA vaccine program
WASHINGTON (AP) — Dr. Vinay Prasad, a prominent critic of the pharmaceutical industry and the Food and Drug Administration, ...
BioPharma Dive9h
FDA set to meet this month on COVID vaccines
The advisory committee meeting is an important step in the process of readying boosters for the fall and winter season, but ...
The FDA names a new vaccine chief with an unsettling record, joining a controversial team
Dr. Vinay Prasad, the FDA's new vaccine chief, has been accused of spreading misinformation about Covid vaccines.
Moderna study shows immune response in older adults for a combo flu and COVID-19 shot
A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...
The American Bazaar8h
FDA names Vinay Prasad as its new vaccine chief
The Food and Drug Administration (FDA) has named Indian American hematologist-oncologist Dr. Vinay Prasad, an outspoken ...
HealthDay on MSN11h
COVID Boosters Might Not Be Updated for Next Season, FDA Commissioner Says
The approach could mean no COVID boosters will be approved in time for next winter’s respiratory disease season, Makary has warned in earlier interviews.